NMD670   Click here for help

GtoPdb Ligand ID: 13343

Synonyms: NMD-670
Compound class: Synthetic organic
Comment: NMD670 is a ClC-1 voltage-sensitive chloride channel inhibitor [1]. It is intended to improve neuromuscular transmission, muscle fiber excitability and muscular function in diseases with underlying compromised transmission between motor neurons and skeletal muscle fibers (e.g. myasthenia gravis, spinal muscular atrophy).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 68.12
Molecular weight 312.12
XLogP 2.22
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H](C(=O)O)OC1=CC=C(C=C1C2=NOC=C2)Br
Isomeric SMILES C[C@H](OC1=C(C=C(Br)C=C1)C2=NOC=C2)C(O)=O
InChI InChI=1S/C12H10BrNO4/c1-7(12(15)16)18-11-3-2-8(13)6-9(11)10-4-5-17-14-10/h2-7H,1H3,(H,15,16)/t7-/m0/s1
InChI Key XKXLEZCOELWNMB-ZETCQYMHSA-N
No information available.
Summary of Clinical Use Click here for help
NMD670 was first evaluated in patients with myasthenia gravis [1], and is a current clinical candidate for spinal muscular atrophy.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05794139 Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy Phase 2 Interventional NMD Pharma A/S